如果您對該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: 卵巢上皮細胞培養(yǎng)基 OEpiCM
產(chǎn)品型號: OEpiCM
產(chǎn)品展商: ScienCell
產(chǎn)品文檔: 無相關(guān)文檔
簡單介紹
卵巢上皮細胞培養(yǎng)基 OEpiCM 卵巢上皮細胞培養(yǎng)基 OEpiCM 上海 安徽 合肥 ScienCell細胞庫
卵巢上皮細胞培養(yǎng)基 OEpiCM
的詳細介紹
Ovarian Epithelial Cell Medium (OEpiCM) is a complete medium designed
for optimal growth of normal human ovarian epithelial cells in vitro. It
is a sterile, liquid medium which contains essential and non-essential
amino acids, vitamins, organic and inorganic compounds, hormones, growth
factors and trace minerals. The medium is serum-free. It is HEPES and
bicarbonate buffered and has a pH of 7.4 when equilibrated in an
incubator with an atmosphere of 5% CO2/95% air. The medium is formulated
(quantitatively and qualitatively) to provide a defined and optimally
balanced nutritional environment that selectively promotes proliferation
and growth of normal human ovarian epithelial cells in vitro.
貨號
|
7311
|
產(chǎn)地
|
美國
|
縮寫
|
OEpiCM
|
規(guī)格
|
500ml
|
用途
|
科研
|
儲存
|
4度,-20度
|
運輸
|
膠冰
|
關(guān)鍵字
|
卵巢上皮細胞培養(yǎng)基 OEpiCM 卵巢上皮細胞培養(yǎng)基 OEpiCM 卵巢上皮細胞培養(yǎng)基 OEpiCM 卵巢上皮細胞培養(yǎng)基 OEpiCM 卵巢上皮細胞培養(yǎng)基 OEpiCM 卵巢上皮細胞培養(yǎng)基 OEpiCM 卵巢上皮細胞培養(yǎng)基 OEpiCM 卵巢上皮細胞培養(yǎng)基 OEpiCM
|
公司簡介
|
合肥星肽生物科技有限公司作為專業(yè)的ScienCell中國代理商,專業(yè)經(jīng)營實驗室科研用原代細胞、原代細胞專用培養(yǎng)基、原代細胞無血清培養(yǎng)基、干細胞、干細胞培養(yǎng)基、干細胞無血清培養(yǎng)基的研究和開發(fā)。合肥星肽生物科技有限公司始終致力于為客戶提供可靠的研究材料以及方便快捷的服務(wù),對購買項目的前期資料提供,中期合同保證,后期貨物跟蹤到 *終售后的確保項目準確到位,都有相關(guān)專業(yè)人士進行維護,確保您在合肥合肥星肽生物科技有限公司公司獲得*上等服務(wù)!
|
聯(lián)系方式
|
何經(jīng)理,合肥星肽生物科技有限公司,Tel:0551-63802898 400-8702-898,
E-mail:info@qingbio.com http://www.huangyuansheng.cn QQ:514713116
|
1.) Friedman E. (2013) "Mirk/dyrk1B kinase in ovarian cancer." Int J Mol Sci. 14: 5560
2.) Cha Y, Kim DK, Hyun J, Kim SJ, Park KS. (2013) " TCEA3 binds to TGF-beta receptor I and induces Smad-independent, JNK-dependent apoptosis in ovarian cancer cells." Cellular Signal. 25: 1245-51.
3.) Takahashi Y, Koyanagi T, Suzuki Y, Saga Y, Kanomata N, Moriya T, Suzuki M, Sato Y. (2012) "Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis." Mol Cancer Res. 10: 1135-46.
4.) Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, Kumar S, Morris R, Steffes CP, Bouwman DL, Mukarah AR, Weaver DW, Gruber SA, Batchu RB. (2011) "MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1." Pharm Res. 28: 3079-90.
5.) Guo AM, Liu X, Al-Wahab Z, Maddippati KR, Ali-Fehmi R, Scicli AG, Munkarah AR. (2011) "Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival." Cancer ChemotherPharmacol.68: 1273-83.
6.) Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Tazi M, Bratasz A, Tong L, Rivera BK, Kalai T, Hideg K, Kuppusamy P. (2010) "Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenylpiperidones: differential cytotoxicity in healthy and cancer cells." Free RadicBiol Med.48: 1228-35.
There are no product questions yet.